1uum
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1uum.jpg|left|200px]] | [[Image:1uum.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1uum", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_1uum| PDB=1uum | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''RAT DIHYDROOROTATE DEHYDROGENASE (DHOD)IN COMPLEX WITH ATOVAQUONE''' | '''RAT DIHYDROOROTATE DEHYDROGENASE (DHOD)IN COMPLEX WITH ATOVAQUONE''' | ||
Line 33: | Line 30: | ||
[[Category: Nours, J Le.]] | [[Category: Nours, J Le.]] | ||
[[Category: Ullrich, A.]] | [[Category: Ullrich, A.]] | ||
- | [[Category: | + | [[Category: Atovaquone]] |
- | [[Category: | + | [[Category: Brequinar]] |
- | [[Category: | + | [[Category: Dihydroorotate dehydrogenase]] |
- | [[Category: | + | [[Category: Fad]] |
- | [[Category: | + | [[Category: Flavoprotein]] |
- | [[Category: | + | [[Category: Nucleotide metabolism]] |
- | [[Category: | + | [[Category: Oxidoreductase]] |
- | [[Category: | + | [[Category: Pyrimidine biosynthesis]] |
- | [[Category: | + | [[Category: Transit peptide]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 11:42:55 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 08:42, 3 May 2008
RAT DIHYDROOROTATE DEHYDROGENASE (DHOD)IN COMPLEX WITH ATOVAQUONE
Overview
The flavin enzyme dihydroorotate dehydrogenase (DHOD; EC 1.3.99.11) catalyzes the oxidation of dihydroorotate to orotate, the fourth step in the de novo pyrimidine biosynthesis of UMP. The enzyme is a promising target for drug design in different biological and clinical applications for cancer and arthritis. The first crystal structure of the class 2 dihydroorotate dehydrogenase from rat has been determined in complex with its two inhibitors brequinar and atovaquone. These inhibitors have shown promising results as anti-proliferative, immunosuppressive, and antiparasitic agents. A unique feature of the class 2 DHODs is their N-terminal extension, which folds into a separate domain comprising two alpha-helices. This domain serves as the binding site for the two inhibitors and the respiratory quinones acting as the second substrate for the class 2 DHODs. The orientation of the first N-terminal helix is very different in the two complexes of rat DHOD (DHODR). Binding of atovaquone causes a 12 A movement of the first residue in the first alpha-helix. Based on the information from the two structures of DHODR, a model for binding of the quinone and the residues important for the interactions could be defined. His 56 and Arg 136, which are fully conserved in all class 2 DHODs, seem to play a key role in the interaction with the electron acceptor. The differences between the membrane-bound rat DHOD and membrane-associated class 2 DHODs exemplified by the Escherichia coli DHOD has been investigated by GRID computations of the hydrophobic probes predicted to interact with the membrane.
About this Structure
1UUM is a Single protein structure of sequence from Rattus rattus. Full crystallographic information is available from OCA.
Reference
Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain., Hansen M, Le Nours J, Johansson E, Antal T, Ullrich A, Loffler M, Larsen S, Protein Sci. 2004 Apr;13(4):1031-42. PMID:15044733 Page seeded by OCA on Sat May 3 11:42:55 2008
Categories: Dihydroorotate dehydrogenase | Rattus rattus | Single protein | Antal, T. | Hansen, M. | Johansson, E. | Larsen, S. | Loffler, M. | Nours, J Le. | Ullrich, A. | Atovaquone | Brequinar | Fad | Flavoprotein | Nucleotide metabolism | Oxidoreductase | Pyrimidine biosynthesis | Transit peptide